BioCentury | Jul 27, 2015
Company News

Omeros, Fagron deal

...Omeros granted Fagron exclusive rights to commercialize OMS103 in the U.S. Fagron will pay Omeros a...
...revenue per vial sold. Omeros is eligible for up to $10 million in commercial milestones. Fagron...
...standard arthroscopic irrigation solutions and is in Phase III development. Omeros Corp. (NASDAQ:OMER), Seattle, Wash. Fagron N.V....
Items per page:
1 - 1 of 1
BioCentury | Jul 27, 2015
Company News

Omeros, Fagron deal

...Omeros granted Fagron exclusive rights to commercialize OMS103 in the U.S. Fagron will pay Omeros a...
...revenue per vial sold. Omeros is eligible for up to $10 million in commercial milestones. Fagron...
...standard arthroscopic irrigation solutions and is in Phase III development. Omeros Corp. (NASDAQ:OMER), Seattle, Wash. Fagron N.V....
Items per page:
1 - 1 of 1